$ASH News

Ashland Launches permexa Sodium Caprate To Advance Oral Delivery Of Peptides, Biologics, And GLP‑1 Therapies

Ashland Inc.: Activist Pressure Starts To Pay Off

Ashland board authorizes quarterly dividend

Ashland Is Said To Explore Sale After Getting Takeover Interest

Morgan Stanley Maintains Equal-Weight on Ashland, Raises Price Target to $78

Ashland Inc. 2026 Q3 - Results - Earnings Call Presentation

Wells Fargo Maintains Equal-Weight on Ashland, Raises Price Target to $70

UBS Maintains Buy on Ashland, Raises Price Target to $83

Evercore ISI Group Maintains In-Line on Ashland, Raises Price Target to $73

Ashland (ASH) Could Be 19% Undervalued After Mixed Quarter And Lower EPS View

Ashland Inc. (ASH) Q3 2026 Earnings Call Transcript

Ashland Inc (ASH) Q3 2026 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ...

Ashland Q3 Earnings Call Highlights

Ashland Inc. Q3 2026 Earnings Call Summary

Ashland Analysts Increase Their Forecasts After Strong Q2 Results

Mizuho Maintains Outperform on Ashland, Raises Price Target to $77

BMO Capital Maintains Outperform on Ashland, Raises Price Target to $75

Ashland (ASH) Q3 Earnings Lag Estimates

Ashland (NYSE:ASH) Reports In-Line Q3 and Reaffirms Guidance as a Quality Stock

Ashland (ASH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates